SCHEDULE: Dodge & Cox Boosts Zimmer Biomet Stake to 11.2%

Dodge & Cox, an investment adviser, has reported an increased passive beneficial ownership stake of 11.2% in Zimmer Biomet Holdings, Inc. as of June 30, 2025.

Summary

• Dodge & Cox, an investment adviser, has filed an Amendment No. 4 to Schedule 13G, disclosing its beneficial ownership in Zimmer Biomet Holdings, Inc.
• As of June 30, 2025, Dodge & Cox beneficially owns 22,097,463 shares of Zimmer Biomet's Common Stock.
• This represents 11.2% of the class of securities.
• Dodge & Cox holds sole voting power over 20,878,838 shares and sole dispositive power over 22,097,463 shares.
• No shared voting or dispositive power is reported.
• The shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
• Dodge & Cox Stock Fund, an investment company managed by Dodge & Cox, holds a specific interest of 14,622,400 shares, representing 7.4% of the class.

Sentiment

Score: 7

Explanation: The filing indicates a significant and passive stake by a major investment adviser, Dodge & Cox, in Zimmer Biomet. This suggests a vote of confidence in the company's long-term value proposition from a large institutional investor, which is generally a positive signal for the market, despite being a routine ownership disclosure.

Positives

• A significant passive stake by a reputable investment adviser like Dodge & Cox may signal confidence in Zimmer Biomet's long-term prospects.
• The increase in ownership from previous filings (implied by Amendment No. 4) could be viewed positively by the market, indicating a continued belief in the company's value.

Negatives

• This filing does not contain information that would typically be categorized as negative regarding the issuer's performance or outlook.

Risks

• This filing, a Schedule 13G, primarily reports beneficial ownership and does not detail specific risks related to Zimmer Biomet Holdings, Inc.'s operations or financial health.

Future Outlook

This Schedule 13G filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance from Zimmer Biomet Holdings, Inc. or Dodge & Cox regarding the issuer's future performance.

Industry Context

This filing reflects a significant passive investment by a major asset manager in a leading medical technology company specializing in musculoskeletal healthcare. Such investments are common in the healthcare sector, which is often viewed as a defensive industry with long-term growth potential due to aging populations and advancements in medical treatments.

Stakeholder Impact

• Shareholders: The disclosure of a large, passive institutional stake by Dodge & Cox may instill confidence among existing and potential shareholders, suggesting a belief in the company's value.
• Management: Awareness of a significant institutional holder can influence management's focus on long-term value creation, though Dodge & Cox explicitly states its stake is not for control purposes.

Key Dates

Keywords

Zimmer Biomet Holdings Inc, Dodge & Cox, ZB, Medical Devices, Orthopedics, SEC Filing, Schedule 13G, Beneficial Ownership, Institutional Investor, Investment Adviser